2007
DOI: 10.1016/j.smallrumres.2006.10.023
|View full text |Cite
|
Sign up to set email alerts
|

Juvenile Capri-Paratuberculosis (JCP) in India: Incidence and characterization by six diagnostic tests

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
34
1

Year Published

2007
2007
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(36 citation statements)
references
References 22 publications
1
34
1
Order By: Relevance
“…paratuberculosis (MAP) and is a concern in developed countries 1 . Information on prevalence of JD in India possessing 16.2% (120 million) goat population of the world is limited 2,3,4 . In India, bio-burden of low producing goats and sheep is very high and is taxing the scarce and fragile grazing resources.…”
Section: Introductionmentioning
confidence: 99%
“…paratuberculosis (MAP) and is a concern in developed countries 1 . Information on prevalence of JD in India possessing 16.2% (120 million) goat population of the world is limited 2,3,4 . In India, bio-burden of low producing goats and sheep is very high and is taxing the scarce and fragile grazing resources.…”
Section: Introductionmentioning
confidence: 99%
“…However, both the tests (ELISA and AGID) together detected 33.82% (23/68) serum samples as positive ( In the present study, only 14.28% of the youngest animals (<1 year of age) were found sero-positive rest all were above one year of age which means age has a significant role in disease progression. In a similar study, 47.9% of goat kids were found positive by ELISA (Kumar et al, 2007). According to the metaanalysis of Windsor and Whittington (2009) younger animals are susceptible to MAP infection because intestinal mucosa of newborn is highly permeable and thus it allows MAP to penetrate through the mucosal barrier (Sweeney, 1996).…”
Section: Resultsmentioning
confidence: 99%
“…Recent advances in diagnostics, prophylaxis/vaccination alternative therapeutic modalities (Paolicchi et al, 2003;Tripathi et al, 2006;Kumar et al, 2007Kumar et al, , 2014Munjal et al, 2007;Deb et al, 2011; , 2013a,b,c,d, 2014Mahima et al, 2012;Barad et al, 2014) need to be explored fully in the era of emerging antibiotic resistance. Along with these follow up of appropriate/effective preventive and control measures are very crucial for alleviating high financial impacts due to this important pathogen of animals having zoonotic concerns keeping in view One Health, One Medicine approach (Grant, 2005;Tripathi et al, 2002;Momotani, 2012;Sweeney et al, 2012;Dhama et al, 2013e).…”
Section: Vaccinationmentioning
confidence: 99%